HIV patient testing falls in SA after US aid cuts, data shows
HIV experts have said for months the health ministry was downplaying the impact of the funding loss, and a drop in testing figures might be an early warning sign, followed by a rise in new cases and deaths.
The US state department did not immediately respond to a request for comment.
'This data demonstrates what previous models have shown regarding the impact of Pepfar/USAID cuts on pregnant women and their infants,' said Dvora Joseph Davey, an epidemiologist working on maternal and infant HIV at the University of Cape Town.
She said the impact was clear at five public health clinics where she works in Cape Town, which since the US aid cuts have been under-staffed, with fewer nurses to draw blood needed for viral load tests.
HIV experts said diagnostic testing was also likely affected by the funding cuts, though that data was not available.
The counsellors who used to do rapid diagnostic HIV tests are also gone, and pregnant women are no longer being put on preventive HIV drugs (PrEP) because the counsellors are the ones who used to offer that, Davey said.
In the Johannesburg township of Diepsloot, HIV activist and community leader Sophy Moatshe said it was hard to get HIV patients to seek care because of the stigma, and without health workers reaching out when they miss an appointment, many fall through the cracks.
'These people, they don't want to go to the clinic,' she said outside a community centre.
'If there is nobody to check them, they're going to die.'
The long-term future of HIV-related US assistance remains uncertain in SA and globally, as Trump pursues cuts to the international aid budget in line with his 'America First' agenda.
The cuts have also hit research, including HIV vaccine trials.
Mohale said the government was speaking to prospective local and international donors about covering funding gaps, but declined to give details.
Davey said the data on testing in April, however, was 'a good indication of what's going to happen in the future'.
Reuters
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The South African
5 hours ago
- The South African
Cervical and Cervical Cancer in Focus: A Cross-Continental Fight Led by Movement Health Foundation
In the Lambayeque region of northern Peru, stories of delay and loss echo quietly through generations. They are not captured in photographs or archived in official records, but live in the memories of families who have waited too long for care that never came soon enough. In distant towns and rural communities, the journey to a clinic can take hours, and even then, the tools needed for screening are often out of reach. In South Africa, across the ocean but bound by the same fate, women in Limpopo and KwaZulu-Natal wait—not for doctors, but for answers. The nearest hospital is 60 kilometres away. Transport costs nearly a third of their monthly income. And so, they wait—not just for diagnoses, but for the right to be heard. In these places, cancer is not simply a medical condition. It is the result of geography, of poverty, of a history written without their names. More often than not, it is an inheritance. The fight against it—especially breast and cervical cancer—demands more than science. It demands justice. The cost of delay is not just time. It's lives. Globally, breast cancer is the most commonly diagnosed cancer among women. Cervical cancer is the most preventable. And yet, they continue to take the lives of women in low- and middle-income countries at staggering rates. In South Africa, cervical cancer is responsible for more cancer-related deaths among women than any other type. In Peru, more than 4,000 women were diagnosed with the disease last year—many of them poor, and a disproportionate number Indigenous or Afroperuvian. Too many were diagnosed late, reflecting persistent gaps in early screening and access to timely care. To delay care is to decide who is worthy of survival. In both countries, early screening remains rare, while advanced-stage diagnoses are the norm. In Peru, screening levels for cervical cancer plummeted by 76% during the pandemic. In South Africa, 75% of cervical cancer cases are detected only after the disease has progressed beyond early intervention. And in the townships and rural provinces, where HIV prevalence is high and stigma travels faster than treatment, those odds worsen by the day. The Movement Health Foundation operates outside the spotlight. Instead, it works through local institutions, public clinics, and digital infrastructure, where change is measured not in headlines but in wait times shortened and referrals completed. With the Clinton Global Initiative as its commitment partner, the Foundation is now leading cancer interventions in Peru and South Africa that are designed not just to treat, but to reimagine the system itself. In South Africa, a Progressive Web App developed with Nelson Mandela University is helping women navigate cervical cancer screening—from understanding symptoms, to locating clinics, to preparing for appointments in their home language. The app includes voice input, offline features, and maps for rural areas. In Peru, the model is different, but the need is the same. A workflow coordination tool—originally piloted for maternal health in Cusco—is being adapted to help local clinics track screenings and patient referrals for breast and cervical cancer. The new program, under development in Lambayeque and Arequipa, targets 170,000 women and is built to scale to additional regions by 2026. The legacy of inequality cannot be fixed by apps alone. The question is whether these digital tools are surface patches or the beginning of deeper structural reform. Under new executive director Bogi Eliasen, the Foundation is positioning itself as a bridge between the technological and the political. 'We are not interested in pilots that fade,' Eliasen has said. 'We are building infrastructure that learns, adapts, and becomes public.' It's a bold vision in an industry littered with failed interventions and pilots that collapsed under the weight of poor implementation or vanished when donor funding dried up. But the Movement Health Foundation insists that local partnership, government integration, and community buy-in are non-negotiable. The work in Peru, for example, is embedded within national health policy timelines and budget cycles. In South Africa, the Foundation's collaboration with local institutions is explicit, not adjacent. This is how institutions gain roots—not through speed, but through alignment. The numbers should make us uncomfortable. In 2021, South Africa recorded 356.86 DALYs per 100,000 women for breast cancer—a steep increase from 196.28 in 1990. DALYs measure years of life lost not just from death, but from living with disease. These are years spent in waiting rooms, in silence, in systems that never called your name. Peru fares no better. In rural areas, Indigenous and Afroperuvian women often learn about cancer from other patients, not their doctors. The clinics are centralised, the health literacy campaigns are underfunded, and the result is predictable: women show up too late, and leave too soon. We are not talking about rare conditions. We are talking about preventable diseases with known interventions. The delay is not technical. It is the result of fragile policies and outdated processes, systems that have failed to evolve with the needs of those they serve. A woman in rural South Africa still needs to travel hours to reach care. A woman in northern Peru still needs three separate visits to complete a screening, colposcopy, and treatment. If she misses one, the clock resets. This is not a coincidence. It is a reflection of design—of systems built to be good enough for some, but not for all. And yet, that design is not immutable. It can be rewritten. The Movement Health Foundation is trying to write a different script. One where prevention is not a privilege, where follow-up is not optional, and where a diagnosis is not the beginning of the end. If global health is to mean anything, it must begin with the least protected. Not just in rhetoric, but in protocol. Not just in fundraising, but in follow-through. And so the question remains, not for them, but for us: what does it say about our global priorities when a woman needs to survive a system before she can survive a disease? 'This is not about awareness,' Bogi Eliasen has said. 'This is about consequence.' He's right. The numbers are not just statistics. They are verdicts. And verdicts, if left unchallenged, become legacies. Let's not allow that. By: Lena Whitmere
IOL News
6 hours ago
- IOL News
South Africa's HIV Response: Hope, Tools, and Resolve
South Africa has the world's largest HIV treatment programme, with over 5.5 million people receiving antiretrovirals (ARVs). Yet we still see more than 100 000 new HIV infections each year. That is unacceptable — and preventable. Image: Tumi Pakkies/ Independent Newspapers Earlier this month, more than 3,600 scientists, activists, policymakers, and journalists gathered in Kigali, Rwanda, for the 13th International AIDS Society (IAS) Conference on HIV Science. It was the first time this major global event took place in an African city outside South Africa, marking a powerful recognition of the continent's critical role in the global HIV response. The conference came on the heels of deeply concerning news: in January, the US government announced sharp cuts to funding for the President's Emergency Plan for AIDS Relief (PEPFAR), a move that cast a long shadow over the global fight against HIV, particularly in Africa. The numbers are staggering: of the 40.8 million people living with HIV globally, over 26 million (65%) are in Africa. And more than half of all new infections in 2024 occurred on the continent. A Call to Stay the Course Despite fears about reduced funding, the mood in Kigali was one of resolve. Delegates affirmed their commitment to ending HIV, recognising the extraordinary progress made in Eastern and Southern Africa. Many echoed a common sentiment: "We cannot stop now. We must fight to the end", emphasising the need for sustained commitment and effort to achieve an AIDS-free future. That optimism was reinforced by encouraging developments. The pharmaceutical company Gilead announced that Lenacapavir, a new HIV prevention drug administered via two injections a year, has shown high efficacy in clinical trials. If made widely accessible, this could be a game-changer— especially for those who struggle with daily pill regimens. Further hope came when the US Congress ultimately approved continued PEPFAR funding, although uncertainties remain around the duration and scope of future support. Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad loading What This Means for South Africa South Africa has the world's largest HIV treatment programme, with over 5.5 million people receiving antiretrovirals (ARVs). Yet we still see more than 100 000 new HIV infections each year. That is unacceptable — and preventable. To address this, the government launched the '1.1 Million Campaign' in February to close the gap between those who know their HIV status and those who are virally suppressed. But for this initiative to succeed, we need national mobilisation. Every political leader, community organiser, religious institution, and employer must actively support the campaign. Unfortunately, media coverage has been limited, and public awareness remains low. Doing More with Less With reductions in funding from the Global Fund and PEPFAR, and despite increased domestic investment, every rand in our HIV response must count. Managers and community activists in the health and social development sectors must track data rigorously: Who is being tested? Who is on treatment? Who is virally suppressed? Who is using Pre-Exposure Prophylaxis (PrEP) — and who should be, but isn't? We must also stand firm against stigma. There is no justification for discrimination against people living with HIV or those using preventive treatments like PrEP. They are taking responsible steps to protect themselves and others. They should be commended and supported, not shamed. The Tools Are in Our Hands We now have powerful tools to fight HIV. HIV self-test kits are available free at public clinics and affordable at private pharmacies. Oral PrEP— a once-a-day pill to prevent HIV — is also free at government health facilities. And injectable PrEP, which could significantly improve adherence, is expected to be available next year. Condoms remain a highly effective prevention method. Let's not forget—they also prevent sexually transmitted infections like syphilis and gonorrhoea and help avoid unplanned pregnancies. They are free at all public clinics. Let's also remember the link between HIV and tuberculosis (TB). People with HIV are more susceptible to TB. If you have symptoms or have been in contact with someone with TB, get tested. Early detection saves lives. Health Is Everyone's Business Building a healthier South Africa is not just about medicine—it is about national prosperity. A healthy population is more productive, more resilient, and more able to seize economic opportunity. Each of us has a role to play in protecting our health and the health of our communities. Let's work together to end HIV. The finish line is in sight—but only if we don't stop now. Prof Yogan Pillay is the Director for HIV and TB delivery at the Bill & Melinda Gates Foundation. He was previously the Country Director of the Clinton Health Access Initiative in South Africa and senior director for universal health coverage. He has worked in various capacities at the National Department of Health. In 2021, the University of Cape Town awarded him an honorary doctorate, and in the same year, he was appointed extraordinary professor in the Division of Health Systems and Public Health, Department of Global Health, Stellenbosch University. Foster Mohale is the National Department of Health Spokesperson
Mail & Guardian
8 hours ago
- Mail & Guardian
Acid mine drainage: South Africa can learn from Japan's experience of toxic waste dumping
Mine water has polluted the Klipspruit. Photo: Delwyn Verasamy/M&G This article looks at the treatment of acid mine drainage (AMD) in South Africa and the recent Central Basin decant in Boksburg Lake and compares it with a best practice example in Japan. It demonstrates how environment, social and governance (ESG) practices are relevant to transform the way governments and businesses operate. In 2002, the public learnt about acid mine drainage (AMD) when it occurred in the West Rand near Krugersdorp, Gauteng. This led to serious concerns about the effect of mining on the environment. Additional concerns arose about the government's response to AMD from a policy perspective. During that time only an inter-ministerial committee document of 2010 on AMD existed. Shortly after, the AMD Emergency Works Project was implemented, and the short-term treatment of AMD commenced in the three basins of the Witwatersrand (as per the IMC document) from 2012 to 2016. My research from 2011 to 2017 found that the evolving policy response and social dynamics of AMD were not sufficiently synchronised to deal with similar predicaments in the future. In 2017, the first draft of the Mine Water Management Policy surfaced and was approved in 2022. This policy sets the tone for the desirable management of mine water in South Africa but envisions that treated AMD will contribute to South Africa's water dilemma only by 2040. Thus, a long-term treatment does not exist and in the interim, potential decanting is possible, further affecting communities and the environment. In June 2025, the media reported that the central basin had decanted and the water in Boksburg Lake was not being fit for use. But it's those very people who are dependent on the water who may not heed to the warning, let alone know about it. Several initiatives (such as the National Water and Sanitation Master Plan, the National Integrated Water Security Framework and the Vaal Anti-Pollution Forum) have surfaced to address the serious water crisis in South Africa. The government has put forward the importance of partnerships, that of the private sector and stakeholder participation. But pivotal to these partnerships is the involvement of communities to achieve environmental sustainability. The master plan identifies key actions in the water sector and provides the roles and responsibilities of all stakeholders such as the three tiers of government and the private sector. Japanese example Japan's island of Teshima provides a best practice example of how governments, businesses and communities can work in partnership towards environmental sustainability. In the 1970s, almost a million tonnes of toxic waste was dumped by a company on the western end of the island and open air burning began, harming the community of Teshima. The Kagawa Prefecture (equivalent to local government) certified that the waste was unharmful and provided the authorisation for the disposal. The company had sought the permit under the pretence of earthworm farming. In 1990, the Hyogo Prefectural Police started investigating the concerns raised by the public and exposed the company for violating the Waste Management Act and the illegal dumping stopped. Massive amounts of waste were left on Teshima. The Kagawa Prefecture was of the view that the waste was not classified incorrectly, no impact would be inflicted on the environment and treatment of the waste was not required. In 1993, resident movements were formed and the Teshima community applied for a pollution conciliation for the waste to be removed. In 2000 an agreement was reached to have the waste removed. The Environmental Disputes Coordination Commission took measures of the landfill site due to the environmental risks not being immediately present. In the 1980s Japan adopted a 'pollution must be covered up and hidden' approach. After an almost two-decade long rehabilitation process, this has led to tighter laws and increased fines for illegal waste disposal. This is one of Japan's most dreadful cases and yet one of its biggest victories in terms of environmental justice. The residents suffered for more than 40 years. The cost of the disposal was 80 billion yen (R9 billion), funded by public funds, the prefectural government and the national government. In Teshima the biodiversity is not restored to its natural state and enhancing tourism of the island will take time, but the residents are committed to playing a contributory role, which in essence depicts environmental sustainability. Teshima draws similarities with the Grootvlei Mine. Grootvlei had their water-use licence renewed and revoked over a period of years because of non-compliance and was a major contributor of AMD. Similarly, public funds are used for the environmental rehabilitation process. Japan is an example of a well-established state and South Africa is still developing, and criticism can stem from such a comparison. But Japan and South Africa are part of the G20, which aims to bring together the world's major developed and developing economies to discuss global economic and social issues. The key takeaway from the comparison is the importance of communities for environmental justice and ultimately environmental sustainability. We have similar strong-willed communities in South Africa. Disadvantaged communities are victims of AMD residual. As we aim for environmental sustainability in South Africa, the answers are closer than we think. Communities are critical stakeholders — the residents and the employees. Embedding ESG in business operations can only be done if employees are involved in the process and there is a shared vision for success. Investors use ESG frameworks to assess a company's sustainability efforts and societal impact. Investors are more likely to invest in Japan because of past success stories such as Teshima, which the community was at the forefront of. The same can be adopted in South Africa. If the government is really working towards a sustainable environment and businesses are really considering being ESG driven, or implementing the long-term solution to AMD by 2040 as policy evolves, such partnerships are essential. Dr Suvania Naidoo is an author and an NRF Y rated researcher. The information provided on Teshima comes from her time spent in Japan, Setouchi Olive Foundation documentation, a site visit to Teshima and presentations from researchers at Okayama University. A version of this article was previously published in Mining Weekly.
